Preclinical News and Research

RSS
Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Dry beans reduce risk of mammary cancer

Dry beans reduce risk of mammary cancer

Is rapid transition through menopause linked to earlier onset of heart disease?

Is rapid transition through menopause linked to earlier onset of heart disease?

Leconotide, an investigative calcium channel blocker, shows potential as pain treatment

Leconotide, an investigative calcium channel blocker, shows potential as pain treatment

Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203

Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203

Stromedix awarded U.S. patent for antibody-based therapeutics

Stromedix awarded U.S. patent for antibody-based therapeutics

Lisofylline drug improves type 2 insulin action; reduces harm of fat in preclinical study

Lisofylline drug improves type 2 insulin action; reduces harm of fat in preclinical study

Virotherapy treatment kills prostate cancer cells

Virotherapy treatment kills prostate cancer cells

Biotech venture seeks West Nile virus treatment from antibodies in geese

Biotech venture seeks West Nile virus treatment from antibodies in geese

Ground-breaking test for spem quality

Ground-breaking test for spem quality

New understanding on how aging causes broken bones to heal slowly

New understanding on how aging causes broken bones to heal slowly

Stem cells could be used for personalized cancer treatment

Stem cells could be used for personalized cancer treatment

New drug shows promise for phenylketonuria

New drug shows promise for phenylketonuria

Advaxis wins European patent case involving Lovaxin-C vaccine

Advaxis wins European patent case involving Lovaxin-C vaccine

Novel low-cost immunotherapy for cancer cells

Novel low-cost immunotherapy for cancer cells

New nasal spray vaccine shown to be effective against botulism

New nasal spray vaccine shown to be effective against botulism

New drugs have longer clinical development times despite faster FDA review

New drugs have longer clinical development times despite faster FDA review

Osteotech starts trial for DuraTech BioRegeneration Matrix

Osteotech starts trial for DuraTech BioRegeneration Matrix

Onyx Pharmaceuticals acquires license option on novel JAK2 inhibitors from S*BIO

Onyx Pharmaceuticals acquires license option on novel JAK2 inhibitors from S*BIO

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.